Research & Publications

Publications, Conference Presentations & Patents

  • Presentation Early postnatal rehabilitation mitigates motor, growth, and social deficits in perinatal brain injury. Nov 15, 2025. Simonti, G., Vidva, R., Sanidas, G., Byrd, C., Lowe, C., Triantafyllou, M., Wolff, N., Chandereng, T., Koutroulis, I., Gallo, V., & Kratimenos, P. Program No. PSTR019.10. 2025 Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience, 2025. View abstract
  • Presentation Necrotizing Enterocolitis Selectively Disrupts Pontine Development in the Preterm Brain. Nov 16, 2025. Sanidas, G., Lowe, C., Byrd, C., Vidva, R., Simonti, G., Chandereng, T., Gallo, V., & Kratimenos, P. Program No. PSTR103.21. 2025 Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience, 2025. View abstract
  • Preprint Intrinsic Gestational Timing Governs Human Cerebellar Development After Preterm Birth. September 2, 2025. Sanidas, G., Simonti, G., Ghaemmaghami, J., Woyshner, K., Vidva, R., Wolff, N., Triantafyllou, M., Lowe, C., Vij, A., Sahlin Pettersen, H., Chandereng, T., Koutroulis, I., Stein-O'Brien, G., Sidiropoulos, D. N., Gallo, V. and Kratimenos, P. doi:10.1101/2025.09.01.673244
  • Preprint Prematurity Insults Remodel Cerebellar Development and Behavior. December 16, 2025. Sanidas, G., Simonti, G., Ghaemmaghami, J., Woyshner, K., Wolff, N., Byrd, C., Triantafyllou, M., Lowe, C., Salisbury, H., Goldstein, E., Sathyanesan, A., Vidva, R., Koutroulis, I., Stein-O'Brien, G., Sidiropoulos, D. N., Gallo, V. and Kratimenos, P. doi:10.1101/2025.07.22.664624
  • Publication Review Eph/Ephrin-Mediated Immune Modulation: A Potential Therapeutic Target for Skin Cancer. April 21, 2025. Giannopoulos, K., Karikis, I., Byrd, C., Sanidas, G., Wolff, N., Triantafyllou, M., Simonti, G., Vidva, R., Koutroulis, I., Theocharis, S. and Kratimenos, P. doi:10.3389/fimmu.2025.1539567
  • Publication MyVivarium: A cloud-based lab animal colony management application with real-time ambient sensing. Feb 1, 2025. Vidva, R., Raza, M.A., Prabhakaran, J., Sheikh, A., Sharp, A., Ott, H., Moore, A., Fleisher, C., Netherton, H., Goldstein, E., Pitychoutis, P.M., Nguyen, T.V. and Sathyanesan, A. doi:10.1016/j.csbj.2025.01.025
  • Patent Use of scientifically matched plant supplements combined with antineoplastic compounds for the treatment of hematological malignancies. Patent No. US11478444B2 [Granted] - Oct 25, 2022. Vali, S., Abbasi, T., Stopka, T., Minarik, L., Singh, N. K., Usmani, S., Radhakrishnan, S., Sikora, H., Vidva, R., & Pimkova, K. View patent
  • Publication Computational analysis of cortical neuronal excitotoxicity in a large animal model of neonatal brain injury. Mar 29, 2022. Kratimenos, P., Vij, A., Vidva, R., Koutroulis, I., Delivoria-Papadopoulos, M., Gallo, V., & Sathyanesan, A. doi:10.1186/s11689-022-09431-3
  • Publication Computational Models Accurately Predict Multi-Cell Biomarker Profiles in Inflammation and Cancer. Jul 26, 2019. Fischer, C. L., Bates, A. M., Lanzel, E. A., Guthmiller, J. M., Johnson, G. K., Singh, N. K., Kumar, A., Vidva, R., Abbasi, T., Vali, S., Xie, X. J., Zeng, E., & Brogden, K. A. doi:10.1038/s41598-019-47381-4
  • Publication Predicting response to BET inhibitors using computational modeling: A BEAT AML project study. Jan 7, 2019. Drusbosky, L. M., Vidva, R., Gera, S., Lakshminarayana, A. V., Shyamasundar, V. P., Agrawal, A. K., Talawdekar, A., Abbasi, T., Vali, S., Tognon, C. E., Kurtz, S. E., Tyner, J. W., McWeeney, S. K., Druker, B. J., & Cogle, C. R. doi:10.1016/j.leukres.2018.11.010
  • Presentation AraC-Daunorubicin-Etoposide (ADE) Response Prediction in Pediatric AML Patients Using a Computational Biology Modeling (CBM) Based Precision Medicine Workflow. Nov 29, 2018. Cogle, C. R., Abbasi, T., Singh, N. K., Sauban, M., Raman, R. K., Vidva, R., Tyagi, A., Talawdekar, A. A., Das, A., Kornblau, S. M., Hoff, F. W., Horton, T. M., & Vali, S. doi:10.1182/blood-2018-99-115775
  • Presentation Predicting Response to Dasatinib Using a Computational Model and Its Validation: A Beat AML Project Study. Nov 29, 2018. Tyner, J. W., Druker, B. J., Tognon, C. E., Kurtz, S. E., Drusbosky, L. M., Sahu, D., Vidva, R., Kapoor, S., Azam, H., Kumar, R., Chickdipatti, P. G., Raveendaran, N. T., Gopi, R. P., Abbasi, T., Vali, S., & Cogle, C. R. doi:10.1182/blood-2018-99-115678
  • Presentation Predicting Response to BET Inhibitor in Combination with Palbociclib/Sorafenib Using a Computational Model and Its Validation: A Beat AML Project Study. Nov 29, 2018. Tyner, J. W., Druker, B. J., Kurtz, S. E., Tognon, C. E., Drusbosky, L. M., Vidva, R., Narvekar, Y., Agrawal, A. K., Gera, S., Prasad, S. A., Shyamasundar, V. P., Tunwer, G. S., Abbasi, T., Vali, S., & Cogle, C. R. doi:10.1182/blood-2018-99-115284
  • Patent Combination of nelfinavir, metformin and rosuvastatin for treating cancer caused by aberrations in PTEN/TP53. Patent No. US10098880B2 [Granted] - Oct 16, 2018. Vali, S., Usmani, S., Sultana, Z., Kumar, A., Abbasi, T., & Vidva, R. View patent
  • Presentation Predicting Response to CDK4/6 Inhibitors and Combinations Using a Computational Biology Model and Its Validation: A Beat AML Project Study. Dec 7, 2017. Drusbosky, L. M., Turcotte, M., Castillo, P., Vidva, R., Gera, S., Sauban, M., Bhargav, P., Deep, P., Kapoor, S., Abbasi, T., Vali, S., Tognon, C. E., Kurtz, S. E., Tyner, J. W., Druker, B. J., & Cogle, C. R. View abstract
  • Presentation Predicting Response to BET Inhibitors Using a Computational Model and Its Validation: A Beat AML Project Study. Dec 7, 2017. Drusbosky, L. M., Vidva, R., Gera, S., Lakshminarayana, A. V., Shyamasundar, V. P., Agrawal, A. K., Talawdekar, A., Abbasi, T., Vali, S., Tognon, C. E., Kurtz, S. E., Tyner, J. W., Druker, B. J., & Cogle, C. R. View abstract
  • Presentation Predicting Response to IDH1/IDH2 Inhibitors Beyond IDH Mutations Using a Computational Model and Its Validation: A Beat AML Project Study. Dec 7, 2017. Drusbosky, L. M., Vidva, R., Gera, S., Das, A., Tiwari, K. K., Joseph, V., Mohapatra, S., Lunkad, N., Abbasi, T., Vali, S., Tognon, C. E., Kurtz, S. E., Tyner, J. W., Druker, B. J., & Cogle, C. R. View abstract
  • Presentation A Genomic Signature Predicting Venetoclax Treatment Response in AML Identified By Protein Network Mapping and Validated By Ex Vivo Drug Sensitivity Testing: A Beat AML Project Study. Dec 2, 2016. Drusbosky, L., Abbasi, T., Vali, S., Radhakrishnan, S., Kumar Singh, N., Usmani, S., Parashar, D., Vidva, R., Druker, B. J., Tognon, C. E., Lo, P., Tyner, J. W., & Cogle, C. R. doi:10.1182/blood.V128.22.1713.1713
  • Patent System and method for development of therapeutic solutions. Patent No. US20150302167A1 [Published] - Oct 22, 2015. Vali, S., Abbasi, T., Fernandes, P., Rajagopalan, S., Alam, A., Vidva, R., Nair, P. R., Kapoor, S., Radhakrishnan, S., Sultana, Z., Ramanujan, K. S., Tiwari, K. K., Kumar, A., Singh, N. K., Agrawal, A. K., Talawdekar, A. A., Usmani, S., & Singh, R. View patent
  • Patent Compositions, process of preparation of said compositions and method of treating inflammatory diseases. Patent No. US20150098993A1 [Published] - Apr 9, 2015. Vali, S., Vidva, R., Nair, P. R., Fernandes, P., Abbasi, T., & Radhakrishnan, S. View patent
  • Patent Compositions, process of preparation of said compositions and method of treating inflammatory diseases. Patent No. US20140127295A1 [Published] - May 8, 2014. Vali, S., Vidva, R., Nair, P. R., Fernandes, P., Abbasi, T., & Radhakrishnan, S. View patent
  • Presentation A Predictive Model of an Oral Inflammatory Response. Mar 22, 2014. Fischer, C., Abbasi, T., Vali, S., Nair, P., Vidva, R., Tiwari, K., & Brogden, K. A. View abstract
  • Publication Histatin 5 binds to Porphyromonas gingivalis hemagglutinin B (HagB) and alters HagB-induced chemokine responses. Jan 29, 2014. Borgwardt, D. S., Martin, A. D., Van Hemert, J. R., Yang, J., Fischer, C. L., Recker, E. N., Nair, P. R., Vidva, R., Chandrashekaraiah, S., Progulske-Fox, A., Drake, D., Cavanaugh, J. E., Vali, S., Zhang, Y., & Brogden, K. A. doi:10.1038/srep03904
  • Presentation HBD3 Both Enhances, Attenuates Dendritic Cell MAPK Responses to HagB. Mar 23, 2013. Harvey, L., Recker, E., Raina, M., Radhakrishnan, S., Prasad, S., Vidva, R., Cavanaugh, J., Vali, S., & Brogden, K. A. View abstract
  • Publication Defensin DEFB103 bidirectionally regulates chemokine and cytokine responses to a pro-inflammatory stimulus. Feb 6, 2013. Harvey, L. E., Kohlgraf, K. G., Mehalick, L. A., Raina, M., Recker, E. N., Radhakrishnan, S., Prasad, S. A., Vidva, R., Progulske-Fox, A., Cavanaugh, J. E., Vali, S., & Brogden, K. A. doi:10.1038/srep01232
  • Presentation Predictive Software-Based Mathematical Modeling: A Novel Approach to Development of Oral Therapies for Rheumatoid Arthritis – Validation in a Murine Collagen Induced Arthritis Model. Nov 12, 2012. Singh, G., Vidva, R., Nair, P., Radhakrishnan, S., Fernandes, P., Abbasi, T., Refino, C., Cruz, J. D., & Vali, S. View abstract | doi:10.1002/art.37735
  • Presentation Novel Combination Therapy of Existing Repurposed Therapies Designed by Predictive Software Modeling Shows Profound Impact on Disease Progression in a Murine Collagen Induced Arthritis Model. Nov 12, 2012. Vali, S., Refino, C., Cruz, J. D., Vidva, R., Nair, P., Radhakrishnan, S., Fernandes, P., Abbasi, T., & Singh, G. View abstract | doi:10.1002/art.37735
  • Presentation Insights into the Anti-inflammatory Action of the Soluble Epoxide Hydrolase Inhibitor through Systems Biology based in silico Modeling Approach. Mar 1, 2008. Vali, S., Hegedus, C., Bhattacharjee, C., Vidva, R., Schmelzer, K., Inceoglu, B., & Hammock, B. D. doi:10.1096/fasebj.22.1_supplement.479.13